Ruolo dell'alfuzosina nei disturbi di vuotamento funzionali nella donna

Translated title of the contribution: Role of alfuzosin in the treatment of functional voiding dysfunction in woman

M. D'Armiento, R. Damiano, M. De Sio, S. Perdona, C. Santonastaso, D. Mattace Raso

Research output: Contribution to journalArticlepeer-review

Abstract

Voiding dysfunction of the lower urinary tract represent a diagnostic and therapeutic challenge being the symptoms and urodynamic finding not strictly related. 34 women with urgency-frequency symptoms and post voiding residual urine were treated with alfuzosin 2,5 mg. twice daily alone or associated to oxibutinine 25 mg twice daily in patients with destrusor instability. After 30 days from therapy 69% presented a post void residual urine less than 40 ml, while 76% presented a flow max more than 15 ml/sec. At follow up 12 months the results remained unchanged. Alfuzosin alone or in association with oxibutinin can lower the urinary resistence to flow without modifying the maximum urethral pressure (MUP).

Translated title of the contributionRole of alfuzosin in the treatment of functional voiding dysfunction in woman
Original languageItalian
Pages (from-to)43-45
Number of pages3
JournalArchivio Italiano di Urologia e Andrologia
Volume69
Issue number1 SUPPL.
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Nephrology
  • Urology

Fingerprint Dive into the research topics of 'Role of alfuzosin in the treatment of functional voiding dysfunction in woman'. Together they form a unique fingerprint.

Cite this